Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: Report of five cases

Journal of Diabetes and Metabolic Disorders

Volumn 12, Issue 1, 2013, Pages

  Carvalho, Patrícia Margarida Serra ^a   Silva, Nuno José Marques Mendes ^a   Dias, Patrícia Glória Dinis ^a   Porto, João Filipe Cordeiro ^a   Santos, Lèlita Conceição ^a   Costa, José Manuel Nascimento ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Glucose 6 phosphatase ; Glycogen storage disease type Ia; Hyperlactacidemia; Hyperlipidemia; Hyperuricemia; Hypoglycemia

Indexed keywords

ALLOPURINOL; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CAPTOPRIL; CIPROFIBRATE; CLOBAZAM; ETIRACETAM; FENOFIBRATE; FERROUS SULFATE; FIBRIC ACID DERIVATIVE; FOLIC ACID; GLUCOSE 6 PHOSPHATASE; IRON; NICOTINIC ACID; OMEGA 3 ACID ETHYL ESTER; OMEPRAZOLE; OXCARBAZEPINE; SERTRALINE; TESTOSTERONE; ALENDRONIC ACID PLUS COLECALCIFEROL; CHORIONIC GONADOTROPIN; CORTICOSTEROID; CREATINE KINASE; CYTOSINE; GEMFIBROZIL; GUANINE; IMMUNOSUPPRESSIVE AGENT; LAROPIPRANT PLUS NICOTINIC ACID; LIPID; LOSARTAN; MALTODEXTRIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; STARCH; UNINDEXED DRUG; URIC ACID;

ADULT; ANEMIA; ARTICLE; ATHEROSCLEROSIS; BLEEDING TENDENCY; BONE DENSITY; BRAIN DAMAGE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; COGNITIVE DEFECT; DELAYED PUBERTY; DEPRESSION; DIET THERAPY; DIETARY INTAKE; DRUG WITHDRAWAL; DUODENITIS; ENDOTHELIAL DYSFUNCTION; EPILEPSY; ESOPHAGOGASTRODUODENOSCOPY; FATTY LIVER; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENETIC ANALYSIS; GLUCOSE 6 PHOSPHATASE GENE; GLYCOGEN STORAGE DISEASE; GLYCOGEN STORAGE DISEASE TYPE 1A; GOUT; GROWTH RETARDATION; HEMODIALYSIS; HEPATOMEGALY; HUMAN; HYPERLACTATEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; INTELLIGENCE QUOTIENT; INTRACTABLE EPILEPSY; INTRON; IRON DEFICIENCY ANEMIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LABORATORY TEST; LIVER ADENOMA; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MALE; MISSENSE MUTATION; MUSCLE WEAKNESS; MUTATIONAL ANALYSIS; MYALGIA; ONSET AGE; OSTEOPENIA; OSTEOPOROSIS; PROTEINURIA; RHABDOMYOLYSIS; SHORT STATURE; AMINO ACID SUBSTITUTION; DRUG SUBSTITUTION; END STAGE RENAL DISEASE; ENTERIC FEEDING; GLYCOGEN STORAGE DISEASE TYPE 1; LAPAROTOMY; LIVER BIOPSY; LIVER GRAFT REJECTION; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 84882592647     PISSN: None     EISSN: 22516581     Source Type: Journal    
DOI: 10.1186/2251-6581-12-25     Document Type: Article

References (45)

1. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I. Eur J Pediatr 2002, 161(Suppl 1):S20-S34.
2. Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, Eberschweiler PT, Gajdos V, Labrune P. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis 2011, 6:27. 10.1186/1750-1172-6-27, 3118311, 21599942.
3. Janecke AR, Mayatepek E, Utermann G. Molecular genetics of type 1 glycogen storage disease. Mol Genet Metab 2001, 73(2):117-125. 10.1006/mgme.2001.3179, 11386847.
4. Koeberl DD, Kishnani PS, Bali D, Chen YT. Emerging therapies for glycogen storage disease type I. Trends Endocrinol Metab 2009, 20(5):252-258. 10.1016/j.tem.2009.02.003, 19541498.
5. Chou JY, Mansfield BC. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease. Hum Mutat 2008, 29(7):921-930. 10.1002/humu.20772, 2475600, 18449899.
6. Rake JP, ten Berge AM, Visser G, Verlind E, Niezen-Koning KE, Buys CH, Smit GP, Scheffer H. Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart. Eur J Pediatr 2000, 159(5):322-330. 10.1007/s004310051281, 10834516.
7. Bhattacharya K. Dietary dilemmas in the management of glycogen storage disease type I. J Inherit Metab Dis 2011, 34(3):621-629. 10.1007/s10545-011-9322-8, 21491105.
8. Fernandes J. Inborn metabolic diseases : diagnosis and treatment 2006, 561. Heidelberg: Springer.
9. Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP. Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002, 161(Suppl 1):S112-S119.
10. Bernier AV, Correia CE, Haller MJ, Theriaque DW, Shuster JJ, Weinstein DA. Vascular dysfunction in glycogen storage disease type I. J Pediatr 2009, 154(4):588-591. 10.1016/j.jpeds.2008.10.048, 3607442, 19101686.
11. Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI. Glycogen storage disease in adults. Ann Intern Med 1994, 120(3):218-226. 10.7326/0003-4819-120-3-199402010-00008, 8273986.
12. Bandsma RH, Prinsen BH, van Der Velden Mde S, Rake JP, Boer T, Smit GP, Reijngoud DJ, Kuipers F. Increased de novo lipogenesis and delayed conversion of large VLDL into intermediate density lipoprotein particles contribute to hyperlipidemia in glycogen storage disease type 1a. Pediatr Res 2008, 63(6):702-707. 10.1203/PDR.0b013e31816c9013, 18520334.
13. Bandsma RH, Smit GP, Kuipers F. Disturbed lipid metabolism in glycogen storage disease type 1. Eur J Pediatr 2002, 161(Suppl 1):S65-S69.
14. Wierzbicki AS, Watt GF, Lynas J, Winder AF, Wray R. Very low-density lipoprotein apolipoprotein B-100 turnover in glycogen storage disease type Ia (von Gierke disease). J Inherit Metab Dis 2001, 24(5):527-534. 10.1023/A:1012407609063, 11757580.
15. Bandsma RH, Rake JP, Visser G, Neese RA, Hellerstein MK, Van Duyvenvoorde W, Princen HM, Stellaard F, Smit GP, Kuipers F. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a. J Pediatr 2002, 140(2):256-260. 10.1067/mpd.2002.121382, 11865283.
16. Lee PJ, Celermajer DS, Robinson J, McCarthy SN, Betteridge DJ, Leonard JV. Hyperlipidaemia does not impair vascular endothelial function in glycogen storage disease type 1a. Atherosclerosis 1994, 110(1):95-100. 10.1016/0021-9150(94)90072-8, 7857375.
17. Bali DS, Chen YT, Goldstein JL. Glycogen Storage Disease Type I. Gene Reviews™ 1993,
18. Nagasaka H, Hirano K, Ohtake A, Miida T, Takatani T, Murayama K, Yorifuji T, Kobayashi K, Kanazawa M, Ogawa A, Takayanagi M. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk. Eur J Pediatr 2007, 166(10):1009-16. 10.1007/s00431-006-0372-0, 17206455.
19. Levy E, Thibault L, Turgeon J, Roy CC, Gurbindo C, Lepage G, Godard M, Rivard GE, Seidman E. Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I. Am J Clin Nutr 1993, 57(6):922-9.
20. Melis D, Parenti G, Della Casa R, Sibilio M, Romano A, Di Salle F, Elefante R, Mansi G, Santoro L, Perretti A, Paludetto R, Sequino L, Andria G. Brain damage in glycogen storage disease type I. J Pediatr 2004, 144(5):637-42. 10.1016/j.jpeds.2004.02.033, 15127000.
21. Moses SW. Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr 2002, 161(Suppl 1):S2-9.
22. Minarich LA, Kirpich A, Fiske LM, Weinstei DA, Weinstein DA. Bone mineral density in glycogen storage disease type Ia and Ib. Genet Med 2012, 14:737-741.
23. Schwahn B, Rauch F, Wendel U, Schonau E. Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control. J Pediatr 2002, 141(3):350-6. 10.1067/mpd.2002.126456, 12219054.
24. Wolfsdorf JI. Bones benefit from better biochemical control in type 1 glycogen storage disease. J Pediatr 2002, 141(3):308-10. 10.1067/mpd.2002.127504, 12219049.
25. Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr 2011, 159(3):442-6. 10.1016/j.jpeds.2011.02.031, 3135733, 21481415.
26. Di Rocco M, Calevo MG, Taro M, Melis D, Allegri AE, Parenti G. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease. Mol Genet Metab 2008, 93(4):398-402. 10.1016/j.ymgme.2007.10.134, 18083610.
27. Cassiman D, Libbrecht, Verslype C, Meersseman W, Troisi R, Zucman-Rossi J, Van Vlierberghe H. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol 2010, 53(1):213-7. 10.1016/j.jhep.2010.03.002, 20447711.
28. Lee PJ. Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 2002, 161(Suppl 1):S46-9.
29. Liu PP, De Villa VH, Chen YS, Wang CC, Wang SH, Chiang YC, Jawan B, Cheung HK, Cheng YF, Huang TL, Eng HL, Chuang FR, Chen CL. Outcome of living donor liver transplantation for glycogen storage disease. Transplant Proc 2003, 35(1):366-8. 10.1016/S0041-1345(02)03951-9, 12591443.
30. Marega A, Fregonese C, Tulissi P, Vallone C, Gropuzzo M, Toniutto PL, Baccarani U, Bresadola F, Toso F, Montanaro D. Preemptive liver-kidney transplantation in von Gierke disease: a case report. Transplant Proc 2011, 43(4):1196-7. 10.1016/j.transproceed.2011.03.003, 21620087.
31. Chen YT. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 1991, 5(1):71-6. 10.1007/BF00852851, 2025544.
32. Baker L, Dahlem S, Goldfarb S, Kern EF, Stanley CA, Egler J, Olshan JS, Heyman S. Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int 1989, 35(6):1345-50. 10.1038/ki.1989.133, 2671467.
33. Reitsma-Bierens WC. Renal complications in glycogen storage disease type I. Eur J Pediatr 1993, 152(Suppl 1):S60-2.
34. Wolfsdorf JI, Laffel LM, Crigler JF. Metabolic control and renal dysfunction in type I glycogen storage disease. J Inherit Metab Dis 1997, 20(4):559-68. 10.1023/A:1005346824368, 9266393.
35. Mundy HR, Lee PJ. Glycogenosis type I and diabetes mellitus: a common mechanism for renal dysfunction?. Med Hypotheses 2002, 59(1):110-4. 10.1016/S0306-9877(02)00199-8, 12160694.
36. Yiu WH, Pan CJ, Ruef RA, Peng WT, Starost MF, Mansfield BC, Chou JY. Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney Int 2008, 73(6):716-23. 10.1038/sj.ki.5002718, 2426750, 18075499.
37. Melis D, Parenti G, Gatti R, Casa RD, Parini R, Riva E, Burlina AB, Vici CD, Di Rocco M, Furlan F, Torcoletti M, Papadia F, Donati A, Benigno V, Andria G. Efficacy of ACE-inhibitor therapy on renal disease in glycogen storage disease type 1: a multicentre retrospective study. Clin Endocrinol (Oxf) 2005, 63(1):19-25.
38. Ozen H, Ciliv G, Kocak N, Saltik IN, Yuce A, Gurakan F. Short-term effect of captopril on microalbuminuria in children with glycogen storage disease type Ia. J Inherit Metab Dis 2000, 23(5):459-63. 10.1023/A:1005608113270, 10947200.
39. Chen YT, Scheinman JI, Park HK, Coleman RA, Roe CR. Amelioration of proximal renal tubular dysfunction in type I glycogen storage disease with dietary therapy. N Engl J Med 1990, 323(9):590-3. 10.1056/NEJM199008303230907, 2199830.
40. Lee PJ, Dalton RN, Shah V, Hindmarsh PC, Leonard JV. Glomerular and tubular function in glycogen storage disease. Pediatr Nephrol 1995, 9(6):705-10. 10.1007/BF00868717, 8747109.
41. Restaino I, Kaplan BS, Stanley C, Baker L. Nephrolithiasis, hypocitraturia, and a distal renal tubular acidification defect in type 1 glycogen storage disease. J Pediatr 1993, 122(3):392-6. 10.1016/S0022-3476(05)83422-5, 8441093.
42. Humbert M, Labrune P, Simonneau G. Severe pulmonary arterial hypertension in type 1 glycogen storage disease. Eur J Pediatr 2002, 161(Suppl 1):S93-6.
43. Humbert M, Labrune P, Sitbon O, Le Gall C, Callebert J, Herve P, Samuel D, Machado R, Trembath R, Drouet L, Launay JM, Simonneau G. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J 2002, 20(1):59-65. 10.1183/09031936.02.00258702, 12166582.
44. Ryan IP, Havel RJ, Laros RK. Three consecutive pregnancies in a patient with glycogen storage disease type IA (von Gierke's disease). Am J Obstet Gynecol 1994, 170(6):1687-90. discussion 1690-1.
45. Sechi A, Deroma L, Lapolla A, Paci S, Melis D, Burlina A, Carubbi F, Rigoldi M, Di Rocco M. Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study. J Inherit Metab Dis 2013, 36(1):83-89. 10.1007/s10545-012-9490-1, 22562700.